Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective effect of hyperoside against renal ischemia-reperfusion injury via modulating mitochondrial fission, oxidative stress, and apoptosis
Lin Wu, Qing Li, Simeng Liu, et al.
Free Radical Research (2019) Vol. 53, Iss. 7, pp. 727-736
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Hyperoside: A review on its sources, biological activities, and molecular mechanisms
Qi Wang, Hao‐Cheng Wei, Shengjun Zhou, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2779-2802
Closed Access | Times Cited: 84
Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury
Yongming Chen, Zixian Li, Hongyong Zhang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Traditional Uses, Chemical Constituents, Biological Properties, Clinical Settings, and Toxicities of Abelmoschus manihot L.: A Comprehensive Review
Fei Luan, Qianhong Wu, Yan Yang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 73
Hyperoside: A Review of Its Structure, Synthesis, Pharmacology, Pharmacokinetics and Toxicity
Sijin Xu, Shuaipeng Chen, Wenxin Xia, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 3009-3009
Open Access | Times Cited: 68
Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats
Moein Ala, Mohammad Reza Fallahpour Khoshdel, Ahmad Reza Dehpour
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 50
Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases
Nan Li, Haitao Tang, Liang Wu, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 1, pp. 198-206
Open Access | Times Cited: 51
Total extracts from Abelmoschus manihot (L.) alleviate radiation-induced cardiomyocyte ferroptosis via regulating redox imbalances mediated by the NOX4/xCT/GPX4 axis
Zhongchi Xu, Yupeng Wang, Wenli Yang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118582-118582
Open Access | Times Cited: 6
Small molecules as modulators of regulated cell death against ischemia/reperfusion injury
Dan‐Qian Chen, Yan Guo, Xin Li, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 6, pp. 2067-2101
Closed Access | Times Cited: 23
Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells
Zhen Zhu, Guangxin Luan, Shiqiao Peng, et al.
Phytomedicine (2023) Vol. 119, pp. 154975-154975
Closed Access | Times Cited: 15
The multifaceted roles of natural products in mitochondrial dysfunction
Qianrun Chen, Danhua Ruan, Jiayan Shi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Antidepressant-like effects of hyperoside on chronic stress-induced depressive-like behaviors in mice: Gut microbiota and short-chain fatty acids
Aoqi Song, Cheng Ru, Jingjing Jiang, et al.
Journal of Affective Disorders (2024) Vol. 354, pp. 356-367
Closed Access | Times Cited: 5
Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury
Ling Chen, Yanyan Deng, Jing Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Beneficial Effects of Butyrate on Kidney Disease
Tram N. Diep, Haoxin Liu, Liang‐Jun Yan
Nutrients (2025) Vol. 17, Iss. 5, pp. 772-772
Open Access
The flavonoid hyperoside attenuates the toxic effect of cisplatin on the human ovarian granulosa cells: in vitro model study
Ekramy Elmorsy, Huda A. Al Doghaither, Ayat B. Al‐Ghafari, et al.
Toxicology Mechanisms and Methods (2025), pp. 1-11
Closed Access
Research progress of effective components of traditional Chinese medicine in intervening apoptosis of renal tubular epithelial cells in diabetic kidney disease
Yuxin Gong
Journal of Ethnopharmacology (2025), pp. 119874-119874
Closed Access
Integrating proteomics and network pharmacology to explore the relevant mechanism of Huangkui capsule in the treatment of chronic glomerulonephritis
Chang Wen, Jia Zou, Jia Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Hyperoside Protected Against Oxidative Stress-Induced Liver Injury via the PHLPP2-AKT-GSK-3β Signaling Pathway In Vivo and In Vitro
Haiyan Xing, Ruoqiu Fu, Caiyi Cheng, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 29
Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease
Mingming Zhao, Yi Yu, Rumeng Wang, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 25
Hyperoside Protects HK-2 Cells Against High Glucose-Induced Apoptosis and Inflammation via the miR-499a-5p/NRIP1 Pathway
Jingbo Zhou, Shu Zhang, Xinyi Sun, et al.
Pathology & Oncology Research (2021) Vol. 27
Open Access | Times Cited: 24
Hyperoside protects cardiomyocytes against hypoxia‑induced injury via upregulation of microRNA‑138
Siyi He, Xiaoqiang Yin, Fan Wu, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 4
Open Access | Times Cited: 23
Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
Raquel Silva Neres-Santos, Carolina Victória Cruz Junho, Karine Panico, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3029-3029
Open Access | Times Cited: 23
Natural products for kidney disease treatment: Focus on targeting mitochondrial dysfunction
Jiewu Huang, Ye Liang, Lili Zhou
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Hyperoside ameliorates cerebral ischaemic–reperfusion injury by opening the TRPV4 channel in vivo through the IP 3 -PKC signalling pathway
Lei Shi, Chenchen Jiang, Hanghang Xu, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1000-1012
Open Access | Times Cited: 8
Evidence construction of Huangkui capsule against chronic glomerulonephritis: A systematic review and network pharmacology
Yao Dai, Xixi Chen, Heng Yang, et al.
Phytomedicine (2022) Vol. 102, pp. 154189-154189
Closed Access | Times Cited: 14
UPLC-MS/MS Method for the Determination of Hyperoside and Application to Pharmacokinetics Study in Rat After Different Administration Routes
Wenjing Yuan, Jingjing Wang, Xiaofei An, et al.
Chromatographia (2021) Vol. 84, Iss. 3, pp. 249-256
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top